Xilio Therapeutics Inc (XLO)
1.25
+0.11
(+9.65%)
USD |
NASDAQ |
May 20, 16:00
1.26
+0.01
(+0.80%)
After-Hours: 05:21
Xilio Therapeutics Shareholders Equity (Quarterly): 25.76M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 25.76M |
| December 31, 2023 | 36.83M |
| September 30, 2023 | 52.50M |
| June 30, 2023 | 67.38M |
| March 31, 2023 | 84.79M |
| December 31, 2022 | 105.65M |
| September 30, 2022 | 126.30M |
| Date | Value |
|---|---|
| June 30, 2022 | 144.22M |
| March 31, 2022 | 166.12M |
| December 31, 2021 | 185.43M |
| September 30, 2021 | -136.46M |
| June 30, 2021 | -121.31M |
| December 31, 2020 | -83.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-136.46M
Minimum
Sep 2021
185.43M
Maximum
Dec 2021
50.30M
Average
67.38M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences Inc | 17.54B |
| FibroGen Inc | -228.12M |
| Avalo Therapeutics Inc | -101.08M |
| IGM Biosciences Inc | 161.25M |
| AEON Biopharma Inc | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.61M |
| Total Liabilities (Quarterly) | 56.84M |